United States Healthcare Equipment & Supplies

Cerus Corp (CERS)

Track

Over the last 90 days, Cerus Corp has seen significant insider selling, with a net value of -$202,334. Executives have been the primary sellers. Notable transactions include planned and proposed sales by the Chief Operating Officer, President and CEO, Chief Medical Officer, and Chief Financial Officer, totaling over $2.8 million in sales.
Stock chart
Ticker: CERS Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Jayaraman Vivek K
Chief Operating Officer
1 sale — total 100,000 USD
Planned sale 29 May 2026
Value US$2,615,041.21 | Price 93.21 | Shares 85,815
Proposed sale 29 May 2026
Value US$2,675,466.40 | Price 73.28 | Shares 25,415
Planned sale 1 May 2026
Value US$50,001.00 | Price 3.00 | Shares 16,667
Proposed sale 1 May 2026
Value US$50,001.00 | Price 3.00 | Shares 16,667
Proposed sale 1 May 2026
Value US$214,626.68 | Price 2.82 | Shares 76,209
Planned sale 12 Mar 2026
Value US$273,769.44 | Price 1.66 | Shares 165,200
Planned sale 12 Mar 2026
Value US$742,022.90 | Price 1.66 | Shares 447,757
Planned sale 12 Mar 2026
Value US$211,365.92 | Price 1.66 | Shares 127,544
Planned sale 12 Mar 2026
Value US$168,603.53 | Price 1.66 | Shares 101,740
Sale 9 Mar 2026
Value US$76,029.18 | Price 1.88 | Shares 40,426
Proposed sale 9 Mar 2026
Value US$76,029.18 | Price 1.88 | Shares 40,426
Planned sale 6 Mar 2026
Value US$156,804.03 | Price 2.01 | Shares 78,187
Planned sale 6 Mar 2026
Value US$48,603.29 | Price 2.01 | Shares 24,235
Planned sale 6 Mar 2026
Value US$61,859.65 | Price 2.01 | Shares 30,845
Planned sale 6 Mar 2026
Value US$55,744.88 | Price 2.01 | Shares 27,796
Planned sale 6 Mar 2026
Value US$68,375.52 | Price 2.01 | Shares 34,094
Sale 5 Mar 2026
Value US$126,305.31 | Price 2.06 | Shares 61,233
Planned sale 5 Mar 2026
Value US$113,901.56 | Price 2.06 | Shares 55,225
Proposed sale 5 Mar 2026
Value US$113,901.56 | Price 2.06 | Shares 55,225
Proposed sale 5 Mar 2026
Value US$126,299.19 | Price 2.06 | Shares 61,233
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-02 2026-05-29 PlS Planned sale
2.2
Jayaraman Vivek K

Chief Operating Officer

Officer
85,815 -30.8%
93.21
US$2,615,041 		85,815 -30.8% 93.21 US$2,615,041
2026-05-29 2026-05-29 PrS Proposed sale
2.2
VIVEK K JAYARAMAN

Officer

Officer
25,415
73.28
US$2,675,466 		25,415 73.28 US$2,675,466
2026-05-05 2026-05-01 PlS Planned sale
2.2
Jayaraman Vivek K

Chief Operating Officer

Officer
76,335 -5.2%
436.52
US$1,916,140 		76,335 -5.2% 436.52 US$1,916,140
2026-05-01 2026-05-01 PrS Proposed sale
2.2
VIVEK K JAYARAMAN

Officer

Officer
16,667
3.00
US$50,001 		16,667 3.00 US$50,001
2026-05-01 2026-05-01 PrS Proposed sale
3.3
RICHARD J BENJAMIN

Officer

Officer
76,209
2.82
US$214,627 		76,209 2.82 US$214,627
2026-03-16 2026-03-12 PlS Planned sale
2.2
Jayaraman Vivek K

Chief Operating Officer

Officer
165,200 -8.6%
1.66
US$273,769 		165,200 -8.6% 1.66 US$273,769
2026-03-16 2026-03-12 PlS Planned sale
2.8
Greenman William Mariner

President and CEO

Executive Director
447,757 -8.2%
1.66
US$742,023 		447,757 -8.2% 1.66 US$742,023
2026-03-16 2026-03-12 PlS Planned sale
2.8
Green Kevin Dennis

Chief Financial Officer

Officer
127,544 -10.9%
1.66
US$211,366 		127,544 -10.9% 1.66 US$211,366
2026-03-16 2026-03-12 PlS Planned sale
3.3
Benjamin Richard J

Chief Medical Officer

Officer
101,740 -11.6%
1.66
US$168,604 		101,740 -11.6% 1.66 US$168,604
2026-03-09 2026-03-09 S Sale
3.3
Benjamin Richard J

Chief Medical Officer

Officer
40,426 -4.4%
1.88
US$76,029 		40,426 -4.4% 1.88 US$76,029
2026-03-09 2026-03-09 PrS Proposed sale
3.3
RICHARD J BENJAMIN

Officer

Officer
40,426
1.88
US$76,029 		40,426 1.88 US$76,029
2026-03-09 2026-03-06 PlS Planned sale
2.8
Greenman William Mariner

President and CEO

Executive Director
78,187 -1.4%
2.01
US$156,804 		78,187 -1.4% 2.01 US$156,804
2026-03-09 2026-03-06 PlS Planned sale
3.3
Benjamin Richard J

Chief Medical Officer

Officer
24,235 -2.6%
2.01
US$48,603 		24,235 -2.6% 2.01 US$48,603
2026-03-09 2026-03-06 PlS Planned sale
2.7
Jensen Chrystal

Chief Legal Officer

Officer
30,845 -2.8%
2.01
US$61,860 		30,845 -2.8% 2.01 US$61,860
2026-03-09 2026-03-06 PlS Planned sale
2.8
Green Kevin Dennis

Chief Financial Officer

Officer
27,796 -2.3%
2.01
US$55,745 		27,796 -2.3% 2.01 US$55,745
2026-03-09 2026-03-06 PlS Planned sale
2.2
Jayaraman Vivek K

Chief Operating Officer

Officer
34,094 -1.8%
2.01
US$68,376 		34,094 -1.8% 2.01 US$68,376
2026-03-09 2026-03-05 S Sale
3.3
Benjamin Richard J

Chief Medical Officer

Officer
61,233 -6.1%
2.06
US$126,305 		61,233 -6.1% 2.06 US$126,305
2026-03-09 2026-03-05 PlS Planned sale
2.8
Green Kevin Dennis

Chief Financial Officer

Officer
55,225 -4.4%
2.06
US$113,902 		55,225 -4.4% 2.06 US$113,902
2026-03-05 2026-03-05 PrS Proposed sale
2.8
KEVIN D GREEN

Officer

Officer
55,225
2.06
US$113,902 		55,225 2.06 US$113,902
2026-03-05 2026-03-05 PrS Proposed sale
3.3
RICHARD J BENJAMIN

Officer

Officer
61,233
2.06
US$126,299 		61,233 2.06 US$126,299
Explore more

More insider trading research around Cerus Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America